Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 7/20 | 1.00 |
| ▸ | BACE1 | P56817 | 5/20 | 1.00 |
| ▸ | BCL2 | P10415 | 4/20 | 1.00 |
| ▸ | PSMB5 | P28074 | 4/20 | 1.00 |
| ▸ | SNCA | P37840 | 4/20 | 1.00 |
| ▸ | PGD | P52209 | 4/20 | 1.00 |
| ▸ | PKM | P14618 | 3/20 | 1.00 |
| ▸ | MET | P08581 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | RECQL | P46063 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | APP | P05067 | 2/20 | 1.00 |
| ▸ | ADAMTS4 | O75173 | 2/20 | 1.00 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 1.00 |
| ▸ | CNR1 | P21554 | 2/20 | 1.00 |
| ▸ | CNR2 | P34972 | 2/20 | 1.00 |
| ▸ | RAD52 | P43351 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Epicatechin Gallate SCHEMBL30977096 | 1.00 | DYRK1A (1.00) | DYRK1ABACE1BCL2PSMB5SNCA | |
| Epicatechin Gallate SCHEMBL39046 | 1.00 | DYRK1A (1.00) | DYRK1ABACE1BCL2PSMB5SNCA | |
| (-)-Catechingallate SCHEMBL31181360 | 1.00 | DYRK1A (1.00) | DYRK1ABACE1BCL2PSMB5SNCA | |
| (-)-Catechingallate SCHEMBL4639342 | 1.00 | DYRK1A (1.00) | DYRK1ABACE1BCL2PSMB5SNCA | |
| Epicatechin Gallate SCHEMBL4639313 | 1.00 | DYRK1A (1.00) | DYRK1ABACE1BCL2PSMB5SNCA | |
| Epicatechin Gallate SCHEMBL13014548 | 1.00 | DYRK1A (1.00) | DYRK1ABACE1BCL2PSMB5SNCA | |
| Catechin Gallate SCHEMBL145289 | 1.00 | DYRK1A (1.00) | DYRK1ABACE1BCL2PSMB5SNCA | |
| Epicatechin Gallate SCHEMBL4545330 | 1.00 | DYRK1A (1.00) | DYRK1ABACE1BCL2PSMB5SNCA | |
| Epicatechin Gallate SCHEMBL8426343 | 1.00 | DYRK1A (1.00) | DYRK1ABACE1BCL2PSMB5SNCA | |
| Epicatechin Gallate SCHEMBL31297152 | 1.00 | DYRK1A (1.00) | DYRK1ABACE1BCL2PSMB5SNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122042866-A | Method for separating, detecting and identifying flavonoid component in cocoa | 中国热带农业科学院香料饮料研究所 | 2026-05-15 | — | — | CN | claimed |
| US-20260130395-A1 | Water Dispersible Botanical Compositions | AQUILA BLACK LTD (AU) | 2026-05-14 | — | — | US | claimed |
| WO-2026087667-A1 | METHOD OF MODIFICATION OF WHEY PROTEIN AT ACIDIC PH BY REACTION WITH OXIDIZED PHENOLIC COMPOUNDS, THE MODIFIED PROTEIN COMPOSITION, AND NUTRITIONAL USES OF THE MODIFIED PROTEIN COMPOSITION | ARLA FOODS AMBA (DK) | 2026-04-30 | — | — | WO | claimed |
| EP-3346842-B1 | STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME | NOVONESIS PLANT BIOSOLUTIONS AS (DK) | 2026-03-25 | — | — | EP | claimed |
| EP-4697979-A1 | METHOD OF PRODUCING A MODIFIED PROTEIN COMPOSITION BY REACTION WITH OXIDIZED PHENOLIC COMPOUNDS, THE MODIFIED PROTEIN COMPOSITION, AND NUTRITIONAL USES OF THE MODIFIED PROTEIN COMPOSITION | Arla Foods amba (DK) | 2026-02-25 | — | — | EP | claimed |
| EP-4687495-A2 | GRAPE SEED EXTRACTS AND RELATED SYSTEMS AND METHODS OF MANUFACTURE | E. & J. Gallo Winery (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4340640-B1 | HIGH PROTEIN, MICELLAR CASEIN-CONTAINING NUTRITIONAL LIQUIDS ENRICHED WITH CATECHIN-COMPOUNDS AND METHOD OF PRODUCTION | ARLA FOODS AMBA (DK) | 2026-02-04 | — | — | EP | claimed |
| US-20260027174-A1 | GRAPE SEED EXTRACTS AND RELATED METHODS OF USE | GALLO WINERY E & J (US) | 2026-01-29 | — | — | US | claimed |
| WO-2025201649-A1 | ADVANCED NITRITE REPLACEMENT IN PROCESSED MEATS, FISH, AND DAIRY: MULTIFUNCTIONAL FOOD INGREDIENTS FOR ENHANCED PRESERVATION AND HEALTH BENEFITS | NOVATICA TECHNOLOGIES LTD (GB) | 2025-10-02 | — | — | WO | claimed |
| US-20250275566-A1 | HIGH PROTEIN, MICELLAR CASEIN-CONTAINING NUTRITIONAL LIQUIDS ENRICHED WITH CATECHIN-COMPOUNDS AND METHOD OF PRODUCTION | ARLA FOODS AMBA (DK) | 2025-09-04 | — | — | US | claimed |
| EP-1861078-A2 | A CAPSICUM VARIETY EXHIBITING A HYPER-ACCUMULATION OF ZEAXANTHIN AND PRODUCTS DERIVED THEREFROM | Kalamazoo Holdings, Inc. (US) | 2007-12-05 | — | — | EP | claimed |
| US-20070042026-A1 | Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions | MORNINGSIDE VENTURE INVESTMENTS LIMITED | 2007-02-22 | — | — | US | claimed |
| US-20060185034-A1 | Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom | KALAMAZOO HOLDINGS, INC. (US) | 2006-08-17 | — | — | US | claimed |
| WO-2006086706-A2 | A CAPSICUM VARIETY EXHIBITING A HYPER-ACCUMULATION OF ZEAXANTHIN AND PRODUCTS DERIVED THEREFROM | KALAMAZOO HOLDINGS, INC. (US) | 2006-08-17 | — | — | WO | claimed |
| US-20050175565-A1 | taurine and/or hypotaurine in oral formulations for preventing and treating functional disorders of the pilosebaceous unit | L'OREAL (CH) | 2005-08-11 | — | — | US | claimed |
| EP-1360327-A4 | METHOD FOR IDENTIFYING GENES REGULATING DESIRED CELL PHENOTYPES | GALILEO PHARMACEUTICALS INC (US) | 2005-07-13 | — | — | EP | claimed |
| US-20040133941-A1 | Methods for identifying genes regulating desired cell phenotypes | BOWEN BENJAMIN A (US) | 2004-07-08 | — | — | US | claimed |
| EP-1360327-A1 | METHOD FOR IDENTIFYING GENES REGULATING DESIRED CELL PHENOTYPES | PHYTERA, INC. (US) | 2003-11-12 | — | — | EP | claimed |
| US-20030175678-A1 | Methods for identifying genes regulating desired cell phenotypes | GALILEO LABORATORIES, INC. | 2003-09-18 | — | — | US | claimed |
| WO-2002059374-A1 | METHOD FOR IDENTIFYING GENES REGULATING DESIRED CELL PHENOTYPES | PHYTERA, INC. (US) | 2002-08-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027174-A1 | GRAPE SEED EXTRACTS AND RELATED METHODS OF USE | MAX, VPS28, VEGFA | DYRK1A 89/4885BACE1 372/4885BCL2 1855/4885 |
| US-20260130395-A1 | Water Dispersible Botanical Compositions | TTPA, PNLIP, SRMS | DYRK1A 1725/4885BACE1 3685/4885BCL2 194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.